Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx - Slideshow

Mayne Pharma outlined its U.S. launch strategy for DistributeRx, a digital pharmacy platform, during a March 2026 investor presentation, emphasizing scalability and direct-to-patient distribution models. The business model leverages virtual pharmacy networks to reduce overhead, targeting chronic disease management and specialty medications, with partnerships across healthcare providers and payers. Key revenue drivers include subscription-based services, data analytics for personalized care, and white-label solutions for third-party pharmacies seeking digital transformation. The company highlighted regulatory compliance as a competitive advantage, citing FDA-aligned processes and state-level pharmacy licensing to ensure seamless national expansion. Investor slides underscored cost efficiencies from AI-driven inventory management and telepharmacy integration, positioning DistributeRx as a disruptor in the $500B+ U.S. pharmacy market.